• Je něco špatně v tomto záznamu ?

Benign vs. malignant inferolateral early repolarization: Focus on the T wave

L. Roten, N. Derval, P. Maury, S. Mahida, P. Pascale, A. Leenhardt, L. Jesel, I. Deisenhofer, J. Kautzner, V. Probst, A. Rollin, JB. Ruidavets, J. Ferrières, F. Sacher, D. Heg, D. Scherr, Y. Komatsu, M. Daly, A. Denis, A. Shah, M. Hocini, P....

. 2016 ; 13 (4) : 894-902. [pub] 20151201

Jazyk angličtina Země Spojené státy americké

Typ dokumentu časopisecké články, multicentrická studie, randomizované kontrolované studie, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc17000855

BACKGROUND: Inferolateral early repolarization (ER) is highly prevalent and is associated with idiopathic ventricular fibrillation (VF). OBJECTIVE: The purpose of this study was to evaluate the potential role of T-wave parameters to differentiate between malignant and benign ER. METHODS: We compared the ECGs of patients with ER and VF (n = 92) with control subjects with asymptomatic ER (n = 247). We assessed J-wave amplitude, QTc interval, T-wave/R-wave (T/R) ratio in leads II and V5, and presence of low-amplitude T waves (T-wave amplitude <0.1 mV and <10% of R-wave amplitude in lead I, II, or V4-V6). RESULTS: Compared to controls, the VF group had longer QTc intervals (388 ms vs. 377 ms, P = .001), higher J-wave amplitudes (0.23 mV vs. 0.17 mV, P <.001), higher prevalence of low-amplitude T waves (29% vs. 3%, P <.001), and lower T/R ratio (0.18 vs. 0.30, P <.001). Logistic regression analysis demonstrated that QTc interval (odds ratio [OR] per 10 ms: 1.15, 95% confidence interval [CI} 1.02-1.30), maximal J-wave amplitude (OR per 0.1 mV: 1.68, 95% CI 1.23-2.31), lower T/R ratio (OR per 0.1 unit: 0.62, 95% CI 0.47-0.81), presence of low-amplitude T waves (OR 3.53, 95% CI 1.26-9.88). and presence of J waves in the inferior leads (OR 2.58, 95% CI 1.18-5.65) were associated with malignant ER. CONCLUSION: Patients with malignant ER have a higher prevalence of low-amplitude T waves, lower T/R ratio (lead II or V5), and longer QTc interval. The combination of these parameters with J-wave amplitude and distribution of J waves may allow for improved identification of malignant ER.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc17000855
003      
CZ-PrNML
005      
20170117100514.0
007      
ta
008      
170103s2016 xxu f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.hrthm.2015.11.020 $2 doi
024    7_
$a 10.1016/j.hrthm.2015.11.020 $2 doi
035    __
$a (PubMed)26592849
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a xxu
100    1_
$a Roten, Laurent $u CHU de Bordeaux/IHU Institut de Rythmologie et Modélisation Cardiaque, Université Bordeaux/Inserm U1045, Bordeaux, France; Department of Cardiology, Inselspital, Bern University Hospital, and University of Bern, Bern, Switzerland. Electronic address: laurent.roten@insel.ch.
245    10
$a Benign vs. malignant inferolateral early repolarization: Focus on the T wave / $c L. Roten, N. Derval, P. Maury, S. Mahida, P. Pascale, A. Leenhardt, L. Jesel, I. Deisenhofer, J. Kautzner, V. Probst, A. Rollin, JB. Ruidavets, J. Ferrières, F. Sacher, D. Heg, D. Scherr, Y. Komatsu, M. Daly, A. Denis, A. Shah, M. Hocini, P. Jaïs, M. Haïssaguerre,
520    9_
$a BACKGROUND: Inferolateral early repolarization (ER) is highly prevalent and is associated with idiopathic ventricular fibrillation (VF). OBJECTIVE: The purpose of this study was to evaluate the potential role of T-wave parameters to differentiate between malignant and benign ER. METHODS: We compared the ECGs of patients with ER and VF (n = 92) with control subjects with asymptomatic ER (n = 247). We assessed J-wave amplitude, QTc interval, T-wave/R-wave (T/R) ratio in leads II and V5, and presence of low-amplitude T waves (T-wave amplitude <0.1 mV and <10% of R-wave amplitude in lead I, II, or V4-V6). RESULTS: Compared to controls, the VF group had longer QTc intervals (388 ms vs. 377 ms, P = .001), higher J-wave amplitudes (0.23 mV vs. 0.17 mV, P <.001), higher prevalence of low-amplitude T waves (29% vs. 3%, P <.001), and lower T/R ratio (0.18 vs. 0.30, P <.001). Logistic regression analysis demonstrated that QTc interval (odds ratio [OR] per 10 ms: 1.15, 95% confidence interval [CI} 1.02-1.30), maximal J-wave amplitude (OR per 0.1 mV: 1.68, 95% CI 1.23-2.31), lower T/R ratio (OR per 0.1 unit: 0.62, 95% CI 0.47-0.81), presence of low-amplitude T waves (OR 3.53, 95% CI 1.26-9.88). and presence of J waves in the inferior leads (OR 2.58, 95% CI 1.18-5.65) were associated with malignant ER. CONCLUSION: Patients with malignant ER have a higher prevalence of low-amplitude T waves, lower T/R ratio (lead II or V5), and longer QTc interval. The combination of these parameters with J-wave amplitude and distribution of J waves may allow for improved identification of malignant ER.
650    _2
$a dospělí $7 D000328
650    12
$a elektrokardiografie $7 D004562
650    _2
$a Evropa $x epidemiologie $7 D005060
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a následné studie $7 D005500
650    _2
$a převodní systém srdeční $x patofyziologie $7 D006329
650    _2
$a lidé $7 D006801
650    _2
$a mužské pohlaví $7 D008297
650    _2
$a lidé středního věku $7 D008875
650    _2
$a prevalence $7 D015995
650    _2
$a retrospektivní studie $7 D012189
650    _2
$a míra přežití $x trendy $7 D015996
650    _2
$a fibrilace komor $x diagnóza $x epidemiologie $x patofyziologie $7 D014693
655    _2
$a časopisecké články $7 D016428
655    _2
$a multicentrická studie $7 D016448
655    _2
$a randomizované kontrolované studie $7 D016449
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Derval, Nicolas $u CHU de Bordeaux/IHU Institut de Rythmologie et Modélisation Cardiaque, Université Bordeaux/Inserm U1045, Bordeaux, France.
700    1_
$a Maury, Philippe $u Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
700    1_
$a Mahida, Saagar $u CHU de Bordeaux/IHU Institut de Rythmologie et Modélisation Cardiaque, Université Bordeaux/Inserm U1045, Bordeaux, France.
700    1_
$a Pascale, Patrizio $u CHU de Bordeaux/IHU Institut de Rythmologie et Modélisation Cardiaque, Université Bordeaux/Inserm U1045, Bordeaux, France.
700    1_
$a Leenhardt, Antoine $u Département de Cardiologie et Centre de Référence des Maladies Cardiaques Héréditaires, AP-HP, Hôpital Bichat, Université Paris Diderot, Sorbonne Paris Cité, Paris, France.
700    1_
$a Jesel, Laurence $u Centre Hospitalier Universitaire de Strasbourg, Strasbourg, France.
700    1_
$a Deisenhofer, Isabel $u Deutsches Herzzentrum München, München, Germany.
700    1_
$a Kautzner, Josef $u Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
700    1_
$a Probst, Vincent $u L׳institut du thorax, service de cardiologie du CHU de Nantes, Nantes, France.
700    1_
$a Rollin, Anne $u Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
700    1_
$a Ruidavets, Jean-Bernard $u Centre Hospitalier Universitaire de Toulouse, Toulouse, France.
700    1_
$a Ferrières, Jean $u Department of Cardiology, Toulouse University School of Medicine, Toulouse, France.
700    1_
$a Sacher, Frédéric $u CHU de Bordeaux/IHU Institut de Rythmologie et Modélisation Cardiaque, Université Bordeaux/Inserm U1045, Bordeaux, France.
700    1_
$a Heg, Dik $u CTU Bern, Department of Clinical Research, and Institute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
700    1_
$a Scherr, Daniel $u CHU de Bordeaux/IHU Institut de Rythmologie et Modélisation Cardiaque, Université Bordeaux/Inserm U1045, Bordeaux, France.
700    1_
$a Komatsu, Yuki $u CHU de Bordeaux/IHU Institut de Rythmologie et Modélisation Cardiaque, Université Bordeaux/Inserm U1045, Bordeaux, France.
700    1_
$a Daly, Matthew $u CHU de Bordeaux/IHU Institut de Rythmologie et Modélisation Cardiaque, Université Bordeaux/Inserm U1045, Bordeaux, France.
700    1_
$a Denis, Arnaud $u CHU de Bordeaux/IHU Institut de Rythmologie et Modélisation Cardiaque, Université Bordeaux/Inserm U1045, Bordeaux, France.
700    1_
$a Shah, Ashok $u CHU de Bordeaux/IHU Institut de Rythmologie et Modélisation Cardiaque, Université Bordeaux/Inserm U1045, Bordeaux, France.
700    1_
$a Hocini, Mélèze $u CHU de Bordeaux/IHU Institut de Rythmologie et Modélisation Cardiaque, Université Bordeaux/Inserm U1045, Bordeaux, France.
700    1_
$a Jaïs, Pierre $u CHU de Bordeaux/IHU Institut de Rythmologie et Modélisation Cardiaque, Université Bordeaux/Inserm U1045, Bordeaux, France.
700    1_
$a Haïssaguerre, Michel $u CHU de Bordeaux/IHU Institut de Rythmologie et Modélisation Cardiaque, Université Bordeaux/Inserm U1045, Bordeaux, France.
773    0_
$w MED00156180 $t Heart rhythm $x 1556-3871 $g Roč. 13, č. 4 (2016), s. 894-902
856    41
$u https://pubmed.ncbi.nlm.nih.gov/26592849 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y a $z 0
990    __
$a 20170103 $b ABA008
991    __
$a 20170117100620 $b ABA008
999    __
$a ok $b bmc $g 1179995 $s 961422
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2016 $b 13 $c 4 $d 894-902 $e 20151201 $i 1556-3871 $m Heart rhythm $n Heart Rhythm $x MED00156180
LZP    __
$a Pubmed-20170103

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...